Champions Oncology Inc Total Liabilities
Champions Oncology Inc total liabilities. Based on the latest financial reports, Champions Oncology Inc (CSBR) has total liabilities worth $24.07 Million USD as of January 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check CSBR asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Champions Oncology Inc (1996–2025)
Total liabilities of Champions Oncology Inc from 1996 to 2025. This chart illustrates how Champions Oncology Inc's total liabilities have evolved over time, based on quarterly financial data.
Champions Oncology Inc Competitors by Total Liabilities
The table below lists competitors of Champions Oncology Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
LET co. Ltd
KQ:297890
|
Korea | ₩90.98 Billion |
|
TEKNA HOLDING ASA NK 2
F:8VB
|
Germany | €18.33 Million |
|
DCC plc
LSE:DCC
|
UK | GBX5.52 Billion |
|
Groupe LDLC SA
PA:ALLDL
|
France | €164.91 Million |
|
Spirax Group plc
LSE:SPX
|
UK | GBX1.47 Billion |
|
Adocia
PA:ADOC
|
France | €26.96 Million |
|
Taekyung BK Co Ltd
KO:014580
|
Korea | ₩199.16 Billion |
|
Deneb Investments Ltd
JSE:DNB
|
South Africa | ZAC1.34 Billion |
Liability Composition Analysis (1996–2025)
This chart breaks down Champions Oncology Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see CSBR current and non-current assets.
Liquidity & Leverage Metrics
Champions Oncology Inc Total Liabilities Ratios Explained
Champions Oncology Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.98 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 5.62 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.85 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Champions Oncology Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Champions Oncology Inc (1996–2025)
The table below shows the annual total liabilities of Champions Oncology Inc from 1996 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-04-30 | $28.57 Million | +1.92% |
| 2024-04-30 | $28.04 Million | -5.53% |
| 2023-04-30 | $29.68 Million | +12.91% |
| 2022-04-30 | $26.28 Million | +30.35% |
| 2021-04-30 | $20.16 Million | +28.82% |
| 2020-04-30 | $15.65 Million | +73.39% |
| 2019-04-30 | $9.03 Million | +11.40% |
| 2018-04-30 | $8.10 Million | +6.46% |
| 2017-04-30 | $7.61 Million | +37.41% |
| 2016-04-30 | $5.54 Million | +38.89% |
| 2015-04-30 | $3.99 Million | -29.66% |
| 2014-04-30 | $5.67 Million | +38.66% |
| 2013-04-30 | $4.09 Million | -66.48% |
| 2012-04-30 | $12.20 Million | -3.41% |
| 2011-04-30 | $12.63 Million | +436.35% |
| 2010-04-30 | $2.35 Million | -12.91% |
| 2009-04-30 | $2.70 Million | +166.70% |
| 2008-04-30 | $1.01 Million | +127.93% |
| 2007-04-30 | $444.82K | -33.71% |
| 2006-04-30 | $671.05K | +5.95% |
| 2005-04-30 | $633.34K | +30.69% |
| 2004-04-30 | $484.62K | -30.46% |
| 2003-04-30 | $696.91K | -11.86% |
| 2002-04-30 | $790.69K | +9.03% |
| 2001-04-30 | $725.18K | +38.19% |
| 2000-04-30 | $524.78K | +14.08% |
| 1999-04-30 | $460.00K | +17.95% |
| 1998-04-30 | $390.00K | +11.43% |
| 1997-04-30 | $350.00K | +12.90% |
| 1996-04-30 | $310.00K | -- |
About Champions Oncology Inc
Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft technology platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers translational oncology solutions that utilizes its technology platform … Read more